Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs

Screening of mRNAs and lncRNAs associated with prognosis and immunity of lung adenocarcinoma (LUAD) and used to construct a prognostic risk scoring model (PRS-model) for LUAD. To analyze the differences in tumor immune microenvironment between distinct risk groups of LUAD based on the model classifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Pengchen, Li, Jin, Chen, Jianguo, Lu, Junyan, Hao, Zezhou, Shi, Junfeng, Chang, Qing, Zeng, Zeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065161/
https://www.ncbi.nlm.nih.gov/pubmed/35504892
http://dx.doi.org/10.1038/s41598-022-11052-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065161/
https://www.ncbi.nlm.nih.gov/pubmed/35504892
http://dx.doi.org/10.1038/s41598-022-11052-8

Ejemplares similares